IMMUNOTERAPIA CON IL-2 SOTTOCUTANEA RICOMBINANTE ED INTERFERONE ASSOCIATA A CHIRURGIA NEL CARCINOMA DEL RENE IN STADIO AVANZATO

Translated title of the contribution: Immunotherapy with subcutaneous rIL-2 and IFN plus surgery for advanced renal cell cancer

M. Maffezzini, A. Simonato, C. Lodolo, G. Carmignani

Research output: Contribution to journalArticle

Abstract

Twelve consecutive patients with metastatic renal cell carcinoma were submitted to an integrate treatment plan of immunotherapy with subcutaneous IL-2 and IFN and radical surgery in a pilot study. Partial response were observed in 2 patients, stable disease in 5 patients and progression of disease under treatment were observed in 5. Two RP were maintained for 12 and 18+ months and 1 SD is maintained at 12+ months. Treatment was well tolerated without significant toxicity. Integrated radical surgery and immunotherapy with s.c. IL-2 and IFN can produce occasionally protracted clinical responses.

Translated title of the contributionImmunotherapy with subcutaneous rIL-2 and IFN plus surgery for advanced renal cell cancer
Original languageItalian
Pages (from-to)139-141
Number of pages3
JournalArchivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell"Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences
Volume66
Issue number3
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Immunotherapy with subcutaneous rIL-2 and IFN plus surgery for advanced renal cell cancer'. Together they form a unique fingerprint.

  • Cite this